Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

COSCIENS Biopharma Inc T.AEZS

COSCIENS Biopharma Inc., formerly Aeterna Zentaris Inc., is a specialty biopharmaceutical company engaged in the development and commercialization of a diverse portfolio of pharmaceutical and diagnostic products, including those focused on areas of unmet medical need. Its lead product, macimorelin (Macrilen; Ghryvelin), is an oral test indicated for the diagnosis of adult growth hormone deficiency (AGHD). The Company is also engaged in the development of therapeutic assets and proprietary extraction technology, which is applied to the production of active ingredients from renewable plant resources used in cosmeceutical products (i.e., oat beta glucan and avenanthramides, which are found in skincare product brands like Aveeno and Burt’s Bees formulations) and being developed as potential nutraceuticals and/or pharmaceuticals.


TSX:AEZS - Post by User

Post by oatson Jun 20, 2024 4:26pm
322 Views
Post# 36098767

Merger Vote

Merger VoteAll,

Just wanted to advise that Gilles Gagnon and the rest of the Ceapro board agreed to provide my group with 2 concessons to obtain our "Yes" vote for the merger.

The first concession was that Jenene Thomas's contract would be terminated immediately going forward.  

The second consession was that Gilles Gagnon would not seek rel-election to the board.  

As you can see, the first concession has failed as Jenene Thomas was listed as the investor contact at the bottom of the last AEZS news release.  We will see what the information circular shows as far as who will be seeking re-eleciton to the AEZS board.

If the second concession turns out to be a failed assurance to obtain our "Yes" vote, I will divulge the details of our groups discsuusion with Gilles that took place in January with regards to the plan forward after the merger was completed.  

I would also encourage anyone who spoke to Jolyon Burton from Bloom Burton prior to the merger vote to send me a private message.  I have spoken to a few people who were contacted by Jolyon Burton, apparently his tactics to convince people to vote yes were somewhat unethical.  If you were contacted by Jolyon Burton and experienced this unethical approach, please let me know.





<< Previous
Bullboard Posts
Next >>